title: Barbiturate anesthesia and brain proton spectroscopy.
abstract: OBJECTIVE
  Thiopentone reduces CBF and metabolic rate. Still, it is widely used for sedation during MR spectroscopy. We investigated whether barbiturate anesthesia and preanesthetic fasting have an effect on metabolic ratios in proton MR spectroscopy of the brain.
  
  
  METHODS
  Eight healthy, consenting, male volunteers were studied twice in a random, crossover fashion. The study sessions were conducted during fasting (F) and nonfasting (nonF), with glucose infusion mimicking the fed state. During both sessions, two sets of spectroscopic data were collected, one during the awake state (F or nonF) and one under barbiturate anesthesia (F+B or nonF+B), using TEs of 135 and 270. Spectral areas of N-acetylaspartate (NAA), choline-containing compounds (Cho), and creatine plus phosphocreatine (Cr) were calculated, and the presence of lactate or lipid was noted. Venous blood samples for glucose, beta-hydroxybutyrate, lactate, and electrolytes were collected.
  
  
  RESULTS
  Barbiturate anesthesia caused a 42% reduction in blood lactate levels during fasting, but not during glucose infusion. There were no differences in NAA/Cho, NAA/Cr, or in Cho/Cr between the groups F, nonF, F+B, or nonF+B. No lactate or lipid resonances were detected.
  
  
  CONCLUSIONS
  Barbiturate anesthesia with preanesthetic fasting can be used for proton spectroscopy at TEs of 135 or 270 without interference from NAA/Cho, NAA/Cr, or Cho/Cr or from the appearance of lactate or lipid.
authors.affiliation: Department of Radiology, Turku University Hospital, Finland.
authors.forename: N M
authors.initials: NM
authors.lastname: Lundbom
authors.forename: T
authors.initials: T
authors.lastname: Manner
authors.forename: M
authors.initials: M
authors.lastname: Komu
authors.forename: O
authors.initials: O
authors.lastname: Peltola
authors.forename: K A
authors.initials: KA
authors.lastname: Leino
authors.forename: O A
authors.initials: OA
authors.lastname: Kirvelä
mesh_terms: D000328:Adult; D000771:Anesthesia, Intravenous; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D001921:Brain / Q000187:drug effects*; D002794:Choline / Q000378:metabolism; D003401:Creatine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004734:Energy Metabolism / Q000187:drug effects*; D005950:Glucose Solution, Hypertonic; D006801:Humans; D019344:Lactic Acid / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D010725:Phosphocreatine / Q000378:metabolism; D013874:Thiopental / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D005950:Glucose Solution, Hypertonic; D010725:Phosphocreatine; D001224:Aspartic Acid; D019344:Lactic Acid; C000179:N-acetylaspartate; D013874:Thiopental; D003401:Creatine; D002794:Choline